Sichenzia Ross Ference Carmel LLP Represents WallachBeth Capital in a $2.5 Million Public Offering

Press Release – New York, NY – March 11, 2024 – Sichenzia Ross Ference Carmel LLP represented WallachBeth Capital in a registered direct offering and concurrent private placement of bioAffinity Technologies, a company addressing the need for noninvasive diagnosis of early-stage cancer and diseases of the lung and broad-spectrum cancer treatments. WallachBeth Capital acted as sole placement agent for the Offering. 

The offering consisted of 1,600,000 shares of common stock in a registered direct offering and common warrants to purchase up to 1,600,000 shares of common stock in a concurrent private placement (together with the registered direct offering) at a combined purchase price of $1.5625 per common share. The common warrants issued pursuant to the concurrent private placement will have an exercise price of $1.64 per share.

The Sichenzia Ross Ference Carmel LLP team was led by partners Ross Carmel and Jeffrey Wofford, as well as law clerk Soumya Cheedi